These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma. Ji S, Su X, Zhang H, Han Z, Zhao Y, Liu Q. Oncol Lett; 2019 Feb; 17(2):2400-2408. PubMed ID: 30719113 [Abstract] [Full Text] [Related]
9. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X. Cell Physiol Biochem; 2014 Feb; 33(6):1631-42. PubMed ID: 24902663 [Abstract] [Full Text] [Related]
11. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Li Y, Quan J, Chen F, Pan X, Zhuang C, Xiong T, Zhuang C, Li J, Huang X, Ye J, Zhang F, Zhang Z, Gui Y. Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305 [Abstract] [Full Text] [Related]
12. MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. Hua Y, Liang C, Miao C, Wang S, Su S, Shao P, Liu B, Bao M, Zhu J, Xu A, Zhang J, Li J, Wang Z. Oncol Lett; 2018 Jun; 15(6):9051-9060. PubMed ID: 29805636 [Abstract] [Full Text] [Related]
16. MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR. Xiang C, Cui SP, Ke Y. J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):186-192. PubMed ID: 27072960 [Abstract] [Full Text] [Related]
17. MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP). Gu C, Wang Z, Jin Z, Li G, Kou Y, Jia Z, Yang J, Tian F. Oncotarget; 2017 Nov 03; 8(54):92119-92133. PubMed ID: 29190902 [Abstract] [Full Text] [Related]
18. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma. Yoshino H, Enokida H, Itesako T, Tatarano S, Kinoshita T, Fuse M, Kojima S, Nakagawa M, Seki N. J Hum Genet; 2013 Aug 03; 58(8):508-16. PubMed ID: 23635949 [Abstract] [Full Text] [Related]